ACELRX PHARMACEUTICALS INC Purchase Agreements
11 Contracts & Agreements
- Form of Securities Purchase Agreement, dated January 17, 2024 by and among Talphera, Inc. and Investor Company ITF Rosalind Master Fund L.P (Filed With SEC on January 22, 2024)
- Form of Securities Purchase Agreement, dated January 17, 2024, by and among Talphera, Inc. and entities affiliated with Nantahala Management, LLC (Filed With SEC on January 22, 2024)
- Asset Purchase Agreement, between the Registrant and Vertical Pharmaceuticals, LLC, dated March 12, 2023 (Filed With SEC on November 14, 2023)
- Form of Securities Purchase Agreement, dated July 17, 2023, by and between AcelRx Pharmaceuticals, Inc. and the Purchasers (Filed With SEC on July 21, 2023)
- Form of Securities Purchase Agreement, dated December 27, 2022 (Filed With SEC on December 29, 2022)
- Securities Purchase Agreement, dated August 3, 2022, between AcelRx Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 4, 2022)
- Purchase Agreement between the Company and the Purchasers, dated November 15, 2021 (Filed With SEC on November 15, 2021)
- Purchase Agreement between the Company and the Purchasers, dated July 22, 2020 (Filed With SEC on July 23, 2020)
- SUBSEQUENT PURCHASE AND SALE AGREEMENT between ARPI LLC, as Seller, and PDL BIOPHARMA, INC., as Purchaser Dated as of September 18, 2015 TABLE OF CONTENTS (Filed With SEC on November 3, 2015)
- PURCHASE AND SALE AGREEMENT between ACELRX PHARMACEUTICALS, INC., as Seller, and ARPI LLC, as Purchaser Dated as of September 18, 2015 TABLE OF CONTENTS (Filed With SEC on November 3, 2015)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 30, 2012)